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Samenvatting
Veel landen in de wereld kampen met de uitdaging van stijgende zorgkosten, die vaak 
harder stijgen dan het BNP of het besteedbaar inkomen. In een poging de zorgkosten te 
beheersen, maar ook om kwaliteit en toegankelijkheid te bevorderen, hebben overheden 
een splitsing tussen inkoop en levering van zorg in het zorgsysteem ingevoerd. 
Financiers van de zorg (zoals lokale overheden, werkgevers, zorgverzekeraars) vervullen 
de rol van zorginkopers; zij selecteren zorgaanbieders, contracteren zorgaanbieders 
en beheren inkooprelaties met gecontracteerde aanbieders. Dit is wat ik inkoop van 
zorg noem. Tegelijkertijd vindt er ook inkoop voor de zorg plaats. Zorgaanbieders, 
zoals ziekenhuizen, klinieken, huisartsen, moeten ook leveranciers van medische en 
niet-medische goederen en diensten selecteren, contracteren en relaties met deze 
leveranciers beheren. Beide soorten inkoop- en leveranciersmanagement in de zorg 
moeten professioneel geschieden om de financiële houdbaarheid van de zorgsector te 
waarborgen. Ik betoog dat een hoog volwassenheidsniveau van inkoop noodzakelijk is, 
met name bij inkoop van zorg. Inkoop met hoge volwassenheid start met het perspectief 
van de eindgebruiker; in de zorg is dat de patiënt. Inkoop van zorg en inkoop voor de 
zorg moeten beiden gericht zijn op het bereiken van de beste waarde voor de patiënt, 
met andere woorden, de best mogelijke uitkomsten per bestede euro. Inkoop en 
leveranciersmanagement in de zorg moet zich ontwikkelen van een “zero-sum game” 
met weinig vertrouwen naar een “positive-sum game” met optimaal vertrouwen, waarbij 
inkopers erop gericht zijn samen met partner-leveranciers waarde voor de patiënt te 
realiseren tegen de best mogelijke condities.
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Abstract
Many countries across the globe face the challenge of increasing healthcare costs, often 
increasing faster than GDP or personal income. In an effort to manage these costs, but 
also to improve the quality and accessibility of healthcare, governments have introduced 
a purchaser-provider split in the healthcare system. Healthcare financers, such as local 
governments, employers and health insurers exercise the role of healthcare purchasers. 
They select and contract providers, and manage buyer-supplier relationships with 
contracted providers. This is what I call purchasing of care. At the same time, purchasing 
for care takes place. Healthcare providers, such as hospitals, clinics and family doctors 
select and contract suppliers of clinical and non-clinical goods and services, and 
manage relationships with these suppliers. Both types of purchasing and supply 
management in healthcare need to be executed professionally, in order for a healthcare 
system to remain financially sustainable. I argue that a high level of purchasing maturity 
is needed, especially in purchasing of care. High-maturity purchasing starts from 
the perspective of the end customer, which is the patient in the healthcare sector. 
Purchasing of care and purchasing for care should both be oriented towards achieving 
the best value for the patient, which means the best possible health outcomes per euro 
spent. Purchasing and supply management in healthcare needs to develop from a low 
trust zero-sum game to an optimal trust positive-sum game with purchasers aiming to 
realise patient value with supplier-partners under the most favourable conditions.
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1. Introduction
Dear Rector Magnificus,
Dear board members of the Vereniging Trustfonds,
Dear dean of Rotterdam School of Management,
Dear vice-dean of the institute of Health Policy & Management,
Dear colleagues and students,
Dear family and friends,
Dear distinguished guests,
The health sector forms a large and growing part of GDP across the globe. Financers, 
such as national and local governments and insurers, face the challenge of using these 
ever increasing budgets to purchase high-quality health services and meet the demands 
of their populations. In many countries, healthcare spending is growing at a faster rate 
than GDP or household disposable income1 (Figure 1). When we take the Netherlands 
as an example, healthcare spending exceeds our collective spending on defence, 
education, police and infrastructure together2.
Many wonder whether the Dutch healthcare system is financially sustainable in the long 
run, and many question the benefits of ten years of healthcare as a regulated market 
system. In 2006, a purchaser-provider split was introduced in the Netherlands, with the 
aim to improve quality, accessibility and affordability of healthcare. Following recent 
1 www.oecd.org
2 www.rijksbegroting.nl
Figure 1: Indexed growth of health spending (highest), GDP (middle), and household disposable 
income (lowest line) for selected countries (based on OECD figures of 2016; * denotes break in 
data collection or measurement method)
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reforms in healthcare and social care, municipalities and health insurers are responsible 
for purchasing care with an annual value of approximately 80 billion euros. How this 
money is actually distributed among providers of care is determined by purchasing 
policies and processes, and ultimately by the behaviours of purchasing professionals 
(although they may not always refer to themselves as purchasers). The contracted 
providers, in turn, spend part of their budget again on purchasing. This determines in 
part to what extent these care providers are financially healthy or not. My research is 
motivated by questions related to how these purchasers behave, what policies and 
procedures they follow, and what their purchasing behaviour ultimately means for the 
quality of the goods and services they purchase.
The main title of this inaugural address is “Purchasing Value”. This title can be read and 
understood in two different ways. First, it can refer to the purchasing of value. This 
relates to the question if and how a purchasing process leads to selecting the most 
valuable alternative. Second, the title can refer to the value of purchasing. This relates 
to the question if and how the purchasing function is of value to its stakeholders. The 
relationship between the two different meanings is clear: a purchasing function is most 
valuable to its stakeholders if it selects providers and products that create the best value.
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2. Purchasing and supply management (PSM)
Before we continue, it is important to define the term purchasing. In the subtitle of this 
paper, I use the term purchasing and supply management. I actually prefer this term to 
just purchasing. Purchasing and supply management, often abbreviated as PSM, refers 
to a business process, or in other words, a set of activities. It refers to the activities 
organisations engage in to ensure that the goods and services they need from their 
suppliers are available at the right time, in the right place, of the right quality, and at 
acceptable cost. Without the supply of such goods and services, the buying organisation 
may be forced to halt its production processes and fail to achieve its mission. Take as an 
example Volkswagen, who had to halt production in six factories this August because of 
a contract dispute with a Bosnian supplier3.
In my teaching I use a definition of purchasing and supply management which builds on 
definitions provided by Van Weele (2010) and Wynstra (2006). The need for an adapted 
definition arises from the fact that in healthcare, the purchaser of health services often 
does not acquire the services for its own use. I thus define purchasing and supply 
management as:
“The design, initiation, control and evaluation of activities within and between 
organisations aimed at securing inputs from suppliers at the most favourable 
conditions.”
Some view purchasing as a purely operational process, such as placing and managing 
orders, as just selecting suppliers, or as running a tendering procedure. Such views of 
purchasing do not do justice to the scope of purchasing. As a field of academic study, 
and therefore also as the object of study of this endowed chair, purchasing and supply 
management encompasses strategic, tactical and operational processes. In a recent 
review of purchasing process models, one of my Master students identified 35 different 
models that describe the activities that make up purchasing and supply management 
(Chen, 2016).
I have tried to capture the most important purchasing and supply management activities 
in one picture, based on the results of Chen’s study (Figure 2). Any former students in the 
room today will recognise that this is a further development of the model I have thus far 
used in my courses Purchasing & Supply Management and Healthcare Procurement & 
Value Chain Management.
3 See http://www.bloomberg.com/news/articles/2016-08-22/
vw-restarts-talks-as-supplier-feud-expands-to-golf-production
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Figure 2: PSM process wheel
Using the term purchasing and supply management instead of just purchasing 
better captures the total set of strategic, tactical and operational activities, given that 
some scholars associate “purchasing” with more operational processes and “supply 
management” with more strategic processes (cf. Burt et al., 2003; Cousins et al., 2008). 
The development of purchasing and supply management from a clerical to a strategic 
function has been well documented elsewhere (e.g., Rozemeijer, 2009; Van Weele, 
2010). My main message here is that purchasing and supply management is of strategic 
importance, includes activities within and between organisations, and covers a full range 
of (strategic) analysis, strategy development, supplier selection, order management, and 
supplier relationship management activities.
My chair is about purchasing and supply management in healthcare. Why take a specific 
look at PSM in the healthcare sector? PSM in the healthcare sector is in part very similar 
to PSM elsewhere, and in part very special. There are basically two quite distinct areas of 
purchasing and supply management in healthcare. I have termed these purchasing of 
care and purchasing for care4 (see Figure 3).
4 Note that I use purchasing here, as well as later in this text, as short-hand for purchasing and 
supply management.
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Figure 3: PSM in healthcare = purchasing for care + purchasing of care
Purchasing of care refers to the process through which healthcare financers (e.g. 
health insurers) select, contract and manage relationships with healthcare providers 
(e.g. hospitals and GPs). This type of purchasing and supply management in healthcare 
takes place in countries with a purchaser-provider split (Figueras et al., 2005). In the 
Netherlands, this is the process we call zorginkoop. Purchasing for care refers to the 
process through which healthcare providers select, contract and manage relationships 
with suppliers of clinical and non-clinical inputs. As an example think of the Erasmus 
Medical Centre (pictured on the cover of this inaugural address booklet) purchasing 
hospital beds or cancer drugs. 
While purchasing of care and purchasing for care could be studied separately, there 
are good reasons to study the two areas together. First of all, an integrated approach 
enables a supply chain, or rather, a supply network perspective on value creation in 
healthcare, including patients, financers, health service providers, suppliers of clinical 
and non-clinical inputs and government (cf. Allen et al., 2009; Sanderson et al., 2015). 
This creates opportunities for optimisation along the supply network. Second, the supply 
network is becoming more integrated in practice. Suppliers of medical technology are 
developing propositions for care financers, and financers are involved in negotiations 
with suppliers of, for instance, pharmaceuticals.
Now that I have defined purchasing, or rather purchasing and supply management, I turn 
to the concept of value.
16  Purchasing Value
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3. What is value?
In this inaugural lecture, I would like to set out a path to study how value can be 
purchased in healthcare, such that purchasing creates value in healthcare. But first, 
we need to define the concept of value. I build on my own background in marketing 
management (see for instance Stoelhorst & Van Raaij, 2004), also taking into account 
how others, such as Van de Klundert (2009), treat the value concept in healthcare.
The most straightforward definition of value is benefits divided by costs. Decision-
makers can evaluate alternatives by comparing the benefits of each alternative and the 
costs of each alternative. Three important issues need to be raised. First, that value is in 
the eye of the beholder: it is the decision-maker’s (subjective) assessment of benefits 
and costs that determines the perceived value of an alternative. Second, that costs 
include monetary and non-monetary costs, including efforts, (waiting) time, anxiety and 
stress. This variable is therefore also often labelled “sacrifices”. And third, that benefits 
includes notions like quality, outcomes, and satisfaction of needs (cf. Lindgreen & 
Wynstra, 2005).
The value of an alternative course of action increases if benefits increase against similar 
or lower cost, or if costs decrease for the same, or improved benefits.
Since value is in the eye of the beholder, stakeholders may assess the value of a certain 
alternative differently. It is thus important to evaluate alternatives from the perspectives 
of the various stakeholders (Yong et al., 2010). Purchasing is about making decisions 
about what inputs to secure, from which suppliers, and at which conditions. In a 
purchasing situation, typical stakeholders include the user of the product, the financer, 
the purchaser and the supplier/provider. Other actors, such as the government or the 
public, may be stakeholders as well in certain purchasing situations. In purchasing of 
care, stakeholders include the healthcare provider, physicians employed by the provider, 
patients, the healthcare financer, politicians and the public. In purchasing for care, for 
instance, purchasing a certain type of pacemaker, stakeholders include the physician, 
hospital management, the purchaser, the patient and the insurer. 
When assessing value, it is also important to distinguish between the short-term and the 
long-term value of purchasing decisions. Certain courses of action may increase value in 
the short-term, but decrease value in the long-term. Bundling volumes with one supplier 
may lead to price reductions in the short run, but to loss of competitiveness in a supply 
market in the long run. Certain courses of action, such as limiting access to expensive 
experimental treatments, may increase value for one stakeholder (e.g. the public), but 
destroy value for another stakeholder (a specific patient).
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If we want to assess the relative value of purchasing alternatives in healthcare, we need 
to assess the benefits and costs of these alternatives, both in the short-term and the 
long-term, for different stakeholders, including consumers affected as patients/clients, 
professionals such as physicians, nurses and other caregivers, provider organisations 
and their management, financers/funders of care, politicians, and the public (e.g. as tax 
payers).
The assessment of value is subjective and driven by the values of the particular 
stakeholder. Such values could include autonomy for medical professionals, solidarity for 
the public, small government for politicians, and best possible care for a patient.
Value is a hot currency today in healthcare. Michael Porter, with colleagues, drives an 
agenda for value-based healthcare (VBHC) (Porter, 2009; Porter, 2010; Porter & Kaplan, 
2016). This concept built around health outcome measures has been adopted in various 
countries and by various actors in the healthcare sector, including our own Erasmus 
Medical Centre5. The Centers for Medicare and Medicaid Services (CMS) in the US is 
promoting hospital value-based purchasing (HVBP), a program in which hospital are 
rewarded for quality, not just quantity (VanLare & Conway, 2012). The Affordable Care 
Act, colloquially knowns as Obamacare, also promotes value-based insurance design 
(VBID) in healthcare (Chernew et al., 2007). This is about benefit plans that incentivise 
consumers to make cost-effective health choices. In other words, value is used in 
healthcare today to denote concepts and designs that emphasise health outcomes for 
patients, quality in combination with quantity, and cost-effective choices.
5 http://www.erasmusmc.nl/perskamer/archief/2015/5134636/?lang=en
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4. Purchasing for care
Let me now focus first on purchasing for care. How much healthcare organisations 
spend on clinical and non-clinical inputs – as a percentage of total costs – depends on 
the type of organisation. Pharmacies, similar to retailers, have a very high purchasing 
ratio (75% or higher). Dutch hospitals have a typical purchasing ratio of 30% to 40%. 
Analyses of annual reports by the Dutch GPO Intrakoop6 show that organisations in 
social and mental care have typical purchasing ratios of 20% to 25%. Finally, smaller 
practices like GP practices and dentists have purchasing ratios closer to 10%, with 
personnel costs accounting for the vast majority of their budgets.
Lichtenberger et al. (2010) claim that in many countries, purchasing costs of hospitals 
are growing faster than personnel costs. Signals about the degree to which purchasing 
for care receives attention from the boards of Dutch provider organisations are mixed. 
On the one hand, there is a very active community of purchasers in the healthcare 
sector that participate in conferences and other meetings organised by the Dutch 
professional purchasing association NEVI and its sub-chapter NEVI Zorg. On the other 
hand, there are signals that the savings potential for purchasing is not always recognised, 
and that reorganisations and personnel lay-offs are the first remedies of choice when 
healthcare organisations are under financial pressure.
One of the most important themes in purchasing for care is the role of the medical 
professional in the purchasing process. Historically, the medical professional has had 
a big influence on the selection of suppliers and brands, with suppliers rather than 
the purchasing function influencing the purchasing process through the medical 
professional. It is telling that Lichtenberger et al. (2010) identify four classes of hospital 
purchases: capital expenditure, basic indirects, low-preference clinical products, and 
high-preference clinical products. The distinction between low-preference and high-
preference is not common in other industries, and refers to the extent to which medical 
professionals have preferences for certain brands. Preferences for certain products/
brands are often established during medical training, and reinforced through supplier 
visits, free product samples (e.g. for research) and sponsorships. However, many 
countries, including the Netherlands, have increased the transparency of physician-
supplier relationships, and have restricted financial ties (e.g. via consultant positions).
Purchasing for care takes place in a tetradic force field, consisting of the supplier, the 
user, the purchaser, and the board of management of the provider organisation (Figure 
4). The patient is an important stakeholder, but rarely has influence on the product that is 
being purchased. For each type of product, and for each medical professional in a given 
provider organisation, a power analysis of these ties may lead to a different picture. In 
order for purchasing to be meaningfully involved, with the capacity to design, initiate, 
6  www.intrakoop.nl
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control and evaluate the purchasing activities in order to create maximum value, it needs 
to understand, and if possible manage this network of stakeholders. 
All stakeholders should be oriented towards purchasing (and supplying) the product 
that creates maximum value for the patient. The product should help to attain the 
best possible health outcomes for the patient. Other values that may be at play are 
the board’s wish to work efficiently and sustainably, the professional’s wish to work 
with products he or she can use safely and confidently, and the purchaser’s wish to 
buy the product at the most favourable conditions, e.g. from a preferred supplier 
with lower transaction costs. In an ideal situation, the ties between the board and the 
professional and the board and purchasing are of equal strength. Moreover, purchasing 
has a relationship of mutual respect with the medical professional, and works in cross-
functional teams with the medical professional where appropriate. Finally, the supplier 
discusses commercial aspects with purchasing and content issues with the professional, 
or this supplier relationship is mostly with the aforementioned cross-functional team.
However, in practice the situation may be different. The board may be inclined to 
listen more to the medical professional than to purchasing. The relationship between 
professionals and purchasing may be one of conflict and competition. And the supplier 
may be very good at building relationships with health professionals, but may ignore 
the role of purchasing. This creates a situation conducive to supplier-induced demand, 
with potentially few checks and balances on how the provider’s budget is spent. 
Recent research shows that the employment situation of medical specialists may be 
an important factor in whether or not alignment between the medical professional and 
purchasing is achieved. Young et al. (2016) show that US hospitals with a higher share of 
employed physicians have lower purchasing and inventory costs.
Professional purchasing can bring commercial sense to the purchasing process, create 
synergies across departments, bring purchasing decisions in line with other functions, 
integrate suppliers where appropriate and help translate patient needs and demands 
into purchasing requirements. These potential contributions are illustrated nicely in the 
purchasing maturity model (Rozemeijer, 2009; Van Weele, 2010) (Figure 5).
Figure 4: The purchasing tetrad for care
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Figure 5: Purchasing maturity model (based on Rozemeijer (2009) and Van Weele (2010))
The sixth stage in this model describes the situation in which the needs and demands 
of the end user are translated into requirements for purchasing. One possible corollary 
of using patient value as a driver for purchasing is to contract suppliers on the basis of 
the outcomes they (help) generate for patients. This type of outcome-based contracting 
could be an integral part of a provider’s implementation of value-based healthcare. 
However, this involves more risk and outcome uncertainty for the supplier, and requires 
providers to take up a facilitator role in the contract management phase of outcome-
based contracts (Nullmeier et al., 2016). The PhD research of Fabian Nullmeier is 
oriented towards understanding how buyers and suppliers cope with increased outcome 
uncertainty in the contract management phase of outcome-based contracts.
The value of purchasing increases if the purchasing professional can lower the total 
cost of purchased inputs or limit its growth, and accomplish this while health outcomes 
for patients improve. However, purchasing could also destroy value, in case it leads to 
the procurement of low-quality products, inferior service to patients/clients, delays in 
restocking, increasing transaction costs or demotivation of the healthcare professional.
When it comes to purchasing for care, I would like to focus my research on two 
main questions. First, how should the relationship between purchasing and medical 
professionals in the quest for patient value be managed? Second, What is the future of 
outcome-based contracting in purchasing for care?
22  Purchasing Value
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5. Purchasing of care
I now turn to the purchasing of care. This is the process through which financers, or 
funders of care select care providers, contract care providers, and manage buyer-seller 
relationships with care providers. Purchasing of care takes place in all healthcare systems 
with a purchaser-provider split (Figueras et al., 2005). The process is also known as 
healthcare contracting or healthcare commissioning. Financers of care can be public 
or private bodies, and care providers can also be public or private, or a mix thereof. 
Purchasing of care obviously also takes place where healthcare is purchased out-of-
pocket by individuals or via personal voucher or personal budget schemes.
In order to speak of a purchasing process, there needs to be freedom for the purchaser 
to select or not select providers for certain healthcare services and/or freedom in the 
conditions against which services are contracted. Such conditions include price, quality, 
and volume. Through its impact on accessibility, affordability, and quality of care, the 
level of professionalism of healthcare purchasing affects the health of the population the 
purchaser serves (Øvretveit, 2003).
In most cases, purchasing of care takes place in a triadic setting (Figure 6). The purchaser 
of care contracts care providers in order to secure care capacity for the population it 
is responsible for. The purchaser does not consume the services. Consumption and 
delivery of the service take place between consumers and providers. Purchasers can 
include municipalities or governments contracting for their citizens, insurers contracting 
for their insurees, or employers for their employees. As soon as members of such 
populations need care, they become care consumers in this triad. 
Triadic relationships are challenging to manage (Wynstra et al., 2015), and the triadic 
setting in healthcare creates some specific challenges. Purchasers need to understand 
very well what their populations may need in the contract period, in terms of care types, 
quality, quantity, place, and time. These needs have to be translated in appropriate 
contracts with providers. At the same time, purchasers will want to manage their 
exposure to financial risk, and hence manage or influence the care that is actually 
Figure 6: The purchasing triad of care
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consumed and/or actually invoiced. Care consumers will want the best possible care, 
and often only limitedly (or perhaps not at all) pay a discretionary cost for the care 
they consume. At the same time, they want to pay the lowest possible fee/premium/
tax, particularly if they do not need care. Providers can often influence the amount of 
care consumed by a patient, and often earn a discretionary profit from any extra care 
they provide to a patient. There are significant information asymmetries between the 
three parties concerning the true cost of care, the real quality of care, the real need 
of a patient and the most cost-effective treatment for a patient. These are not only 
information asymmetries where one party has more and better information than the 
other; there are also many situations in which the knowledge is not available to any 
party.
Without the appropriate checks and balances, patients in need of care may demand 
more care than is needed, providers may happily provide more care than needed, 
purchasers may increase fees, taxes or premiums to cover for increasing expenses, 
and healthcare costs may rise quickly in a way we can observe in many developed 
economies. This is a problem akin to the Tragedy of the Commons (Hardin, 1968) with 
excessive care consumption by some members of the population having negative 
externalities for others in the population.
Healthcare purchasers are often accused of focusing too much on the cost of care, and 
too little on the quality of care. More specifically, they are accused of focusing on the 
prices and volumes of treatments, rather than on the longer-term effects on the total 
cost of care for a population. This short-term cost focus may be quite understandable 
from the perspective of a risk-bearing purchaser in a system with quickly growing 
healthcare expenses.
A variety of innovations in healthcare purchasing are currently taking place. One of 
these relate to making consumers more aware of the consequences of the choices they 
makes. This can be achieved through co-payments for care, deductibles, and through 
rewards for cost-effective choices. Another of these innovations relate to sharing risks 
of overtreatment with providers. This can be achieved through fixed budgets, fixed 
price per diagnosis-related group (DRG), shared-savings programmes and managed 
care techniques. A third set of innovations relate to a shift from price and volume to 
total cost. Examples include disease management, population-based financing, and 
multi-year contracting with provider groups. And a fourth set of innovations relate to 
a shift from price and volume to quality and health outcomes. Examples in this area 
include selective contracting based on quality, outcome-based contracting, pay-for-
performance (P4P), and value-based healthcare (VBHC).
Not all of these innovations are directed at increasing healthcare value. In fact, some are 
only directed at managing the cost and financial risk for the financer. Such healthcare 
purchasing practices lead to consumer criticism, visible in for instance the consumer 
backlash against managed care in the US (Blendon et al., 1998), or the recently 
announced large scale study into negative consequences of healthcare contracting 
in the Netherlands by the Consumentenbond. There is a real risk that healthcare 
contracting can destroy value instead of increasing it.
Prof. dr. Erik M. van Raaij  25
One road to value destruction is through withholding necessary care from patients. 
An exclusive or excessive focus on cost, especially if it is driven by short-term cost 
containment, can lead to care rationing. This may be detrimental to health outcomes for 
patients and increase healthcare costs in the long run. Another road to value destruction 
is through capital destruction as a result of competition between healthcare providers 
or healthcare financers. Healthy competition is expected to lead to a certain amount of 
“creative destruction”, as competitive forces drive out inefficient actors from a market. 
At the same time, healthcare purchasers should be aware of their potential to destroy 
supply markets, which in the case of healthcare, have often been built using public 
money. As in other industries, healthcare purchasers should also take responsibility 
for managing supply markets. A hospital bankruptcy may result in a region becoming 
deprived of essential healthcare services.
Purchasing and supply management in healthcare thus also includes the responsibility to 
build and maintain a market of healthcare providers that is competitive, and that provides 
sufficient geographic coverage of services. Supplier development techniques are used 
in other industries, like the automotive industry, to build and maintain supply markets of 
sufficient quality and quantity (Sako, 2004). Toyota is a well-known example of building 
and maintaining a high quality supplier network through supplier associations, consulting 
groups, learning teams, and employee exchange (Figure 7). Long-term relationships with 
suppliers are a precondition for this type of supply base management, but the tradition 
of one-year contracting between insurers and providers in the Netherlands is at odds 
with this line of thinking.
The healthcare purchaser should be aware of how it can create value and destroy value. 
Value creation is associated with a focus on health outcomes for patients (as opposed to 
a focus on only prices and volumes), a focus on the long-term, a focus on the total cost 
of care, and a focus on prevention instead of treatment only. One of the big challenges 
is defining and measuring valid outcome indicators for the large variety of medical 
conditions (Eindhoven et al., 2015). A variety of approaches have been taken. Some 
financers, such as health insurers, have started projects to develop healthcare quality 
indicators, often with input from the field. Government agencies have set up national 
quality registries, professional bodies have developed quality indicators based on 
Figure 7: Supplier network learning at Toyota (based on Dyer & Hatch (2004))
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consensus between specialists, and the International Consortium on Health Outcome 
Measurement (ICHOM) have defined global standard sets of outcome measures (Porter 
et al., 2016) (Figure 8).
Value-based healthcare purchasing entails upgrading the healthcare purchasing function 
to the highest development stage of the purchasing maturity model I mentioned earlier. 
At stage six, purchasing derives its strategies, tactics and actions from the needs and 
demands of the end consumer. Dutch healthcare insurers spend about 90 to 95 cents of 
each euro they receive in premiums on healthcare reimbursements. The need for a stage 
six purchasing function fits well with this extremely high purchasing ratio. The higher the 
purchasing ratio of an organisation, the higher the level of purchasing maturity that is 
needed.
High-maturity purchasing functions understand the need for differentiated 
purchasing. Each purchasing category has its specific supply market and user demand 
characteristics (Kraljic, 1983). Supply markets can have higher or lower levels of 
concentration, can consist of larger or smaller provider organisations with more 
or less professional sales functions, and the services provided may be of higher or 
lesser strategic value or cost. Users of the services may number many or few, may 
have common or specific demands, and may be in need of acute or plannable care. 
Purchase categories with different characteristics require different purchasing strategies 
(Ateş, 2014). Hence healthcare purchasers need to have a toolbox full of different 
purchasing tools, so that they can apply differentiated purchasing. Dental care needs to 
be purchased differently than diabetes care or breast cancer care. However, we have 
Figure 8: Example of an ICHOM standard set, for Stroke (ICHOM, 2016)
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yet not identified which purchasing tools should be available in that toolbox and which 
approaches work best in which situations.
When it comes to purchasing of care, I would like to focus my research on two issues. 
First, which designs of the healthcare triad create incentives for consumers, providers, 
and financers to maximise health value for the population served by the financer(s)? 
And second, which tools for provider selection, provider contracting and provider 
relationship management are available or need to be developed, and which tools should 
be used in which circumstances to maximise value for patients?
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6. Tribulations in the healthcare triad
We have already seen that the healthcare triad may not always function to create 
maximum value for patients or for society. When consumer demand for healthcare turns 
the system in a Tragedy of the Commons, financers focus on minimising short-term risk, 
and providers are incentivised to maximise production.
It is quite straightforward to explain such problems as stemming from risk averse and 
opportunistic behaviours of the actors in this triad. If one assumes that each of these 
three agents is a self-interested utility maximiser, and is willing to act opportunistically 
(self-interest seeking with guile (Williamson, 1979)), then much of what can be observed 
in the healthcare triad can be accounted for. These assumptions and explanations fit 
agency theory. Agency theory points to certain types of solutions for these problems, 
such as investments in behaviour and/or output monitoring, and designing the optimal 
contract with the “best” incentives (Eisenhardt, 1989).
An alternative explanation for the same problems in the healthcare triad can be found 
in the concept of “honest incompetence” (Hendry, 2002; Kauppi & Van Raaij, 2015). 
Starting from the assumption that agents are not motivated by self-interest seeking 
with guile, but that they are pro-social and willing to generate utility for others (in 
other words, they are “honest”), problems in value generation could still arise given that 
people are not 100% competent. This “incompetence” is present in all actors in the triad. 
Actors are not fully competent in describing their needs, or in translating the needs of 
the actors into the best course of action in order to fulfil these needs. Hence, we see 
the same kinds of problems agency theory tries to explain on the basis of self-interest 
seeking with guile. However, the recommended solutions are very different: investing 
in training and guidance to resolve the misunderstandings between actors in the 
relationship (Hendry, 2002).
The concept of “honest incompetence” is not a theory in itself, but I think this idea 
can be integrated in stewardship theory. Stewardship theory (Davis et al., 1997) builds 
on the assumption that actors can be stewards of a larger whole, such as society or 
the healthcare system. It is not difficult to imagine that people start working in the 
healthcare sector because they want to be pro-social stewards, not because they 
are self-interested opportunists. However, agency theory is often used to provide 
descriptions of and prescriptions for healthcare purchasing (e.g. Figueras et al., 2005). 
This could be highly counterproductive, as repeated exposure to monitoring and distrust 
from one actor in the relationship erodes the stewardship motivations of the other. Davis 
et al. (1997) present an intriguing diagram of how stewardship and agency motivations 
come together in a kind of prisoner’s dilemma situation (Figure 9).
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Figure 9: When stewards meet opportunists (based on Davis et al. (1997))
One of my earliest observations when I entered the Dutch healthcare sector was the 
lack of trust in some of the relationships in the healthcare triad. Only the relationship 
between provider and consumer (doctor and patient) appears to be a high trust 
relationship, although the public’s trust in doctors in general may have been weakened 
by recent news about the extent to which medical professionals have been receiving 
payments from Medtech and pharmaceutical suppliers7. Research by GfK, together with 
Pauline van Esterik-Plasmeijer and Fred van Raaij, shows that Dutch consumers have 
very little trust in their healthcare insurer8. Finally, the relationship between insurers and 
providers is characterised by extensive contracting, elaborate monitoring and regular 
conflicts, with little room for dialogue and low levels of trust.
It seems that in the Dutch context, the insurer struggles with a legitimacy problem in the 
healthcare triad. Without “meaningful involvement” (Tate et al., 2010) in the triad, they 
risk to become irrelevant, and thus become the victim of bridge decay (Li & Choi, 2009). 
My interest is mostly in the relationship between financer and provider, but it is important 
to acknowledge that one bilateral relationship in a triad cannot exist in isolation from the 
other relations in that triad (Wynstra et al., 2015).
Davis et al. (1997) claim that most value is produced in stewardship relationships rather 
than agency relationships. Research by my colleague Merieke Stevens suggests that there 
is an optimal level of trust, and that buyer-supplier relationships can be hurt by either 
too little or too much trust (Stevens et al., 2015). The fact that insurers invest heavily in 
monitoring to protect against provider opportunism, that provider are generally unwilling 
to share tacit knowledge with insurers, and that both actors underestimate each other’s 
positive intentions, all point towards too little trust in the insurer-provider relationship.
7  https://www.skipr.nl/actueel/id27696-farmaceuten-betalen-miljoenen-aan-artsen-.html
8  https://www.skipr.nl/actueel/id23544-drie-op-tien-nederlanders-wantrouwt-zorgverzekeraar.html
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Healthcare purchasers contribute to the creation or the destruction of trust in the 
insurer-provider relationship through their behaviours and their usage of certain tools 
(see e.g. Medisch Contact, 2016). Together with my colleagues, Merieke Stevens and 
Peter Dohmen, I would like to deepen my understanding of what optimal trust means 
in the healthcare context and how purchasers of care can contribute to high-trust 
financer-provider relationships. I want to do this by adding theories and concepts from 
psychology and sociology to the predominantly economic theories used in research and 
teaching today. 
Lack of trust undermines a good functioning of the healthcare purchasing triad. It 
stimulates “zero-sum” thinking in contract negotiations between financers and providers. 
Lack of trust between actors in the triad may also be conducive to fraudulent behaviour. 
Numbers are scarce, but research in the US suggests that as much as 10% of healthcare 
spending may be due to fraudulent behaviour such as overbilling and kickbacks, where 
a small minority are responsible for a great deal of fraudulent behaviour (Policastro 
& Payne, 2013). Allegations of “massive fraud” in the Dutch system for personal care 
budgets threaten to undermine this arrangement in which care consumers can do their 
own healthcare purchasing. A call for more trust in buyer-supplier relationships also 
requires attention to fraud, in purchasing of care, as well as in purchasing for care. This 
line of research builds on my earlier research on deviant behaviours in purchasing & 
supply management, in particular maverick buying (Karjalainen et al., 2009; Kauppi & Van 
Raaij, 2015).
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7. A value chain perspective
So far I have discussed purchasing for care and purchasing of care separately, but as 
I mentioned earlier, there are good reasons to study the two areas together and to 
explore the interrelationships. The value chain in healthcare has two connotations. The 
first connotation is the chain of activities (and associated providers) that is needed to 
achieve health outcomes for patients. This value chain in healthcare could be called the 
care chain.
Porter defines these activities as monitoring and preventing, diagnosing, preparing, 
intervening, recovering and rehabilitating, and monitoring and managing (Porter & 
Teisberg, 2006). The value chain is slightly different for chronic diseases, and consists 
of screening and preventing, diagnosing and staging, delaying progression, intervening, 
ongoing disease management, management of clinical deterioration (incl. palliative & 
hospice care) (Kim et al., 2013) (Figure 10). 
Coordination across the care value chain is important to create optimal value for 
patients (Cramm & Nieboer, 2012; Otte-Trojel et al., 2014; Van Wijngaarden et al., 2006). 
This means avoiding duplicate work and other non-value-adding activities along the 
chain (e.g. duplicate tests, unnecessary transportation and waiting time) and preventing 
errors during handovers between providers or specialists (Meijboom et al., 2010). Patient 
outcomes can often be improved when providers coordinate their activities better, such 
as when rehabilitative physiotherapy already starts during post-surgery recovery in the 
hospital. Healthcare purchasers play an important in creating the conditions in which 
such coordination is stimulated and facilitated.
The second connotation of the healthcare value chain is the chain of buyers and 
suppliers. This value chain in healthcare could be called the healthcare supply chain, with 
the healthcare triad of consumers, financers, and providers at the end, moving upstream 
towards first tier, second tier and higher tier suppliers of healthcare providers (Figure 11).
Figure 10: The care chain for elective/emergency care and for chronic care (based on Kim et al. 
(2013); Porter & Teisberg (2006))
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Figure 11: Example of a healthcare supply chain for pharmaceuticals (adapted from Bhakoo & 
Chan (2011))
Coordination across the healthcare supply chain is also important to create 
optimal value for patients (Bhakoo & Chan, 2011). Medical technology (medtech), 
pharmaceutical, and other suppliers of clinical and non-clinical inputs should be aware 
of the health outcomes that providers aim to achieve for their patients. Purchasers for 
care, i.e. purchasers working for provider organisations, should create the incentives and 
conditions for suppliers to offer goods and services that contribute optimally to patient 
outcomes and health value. Outcome-based contracting, based on patient outcomes, 
could be such a tool. Suppliers can take an active role in linking the supply chain to the 
care chain by offering products that enable error-free handovers between providers, by 
making products interoperable across providers, and the like. Healthcare suppliers play 
an important role in creating the conditions in which such coordination is stimulated and 
facilitated.
Both value chains in healthcare are in reality value networks, with not just 
one-directional relationships in a straight line, but with feedback loops, reciprocal 
relationships of buyers that are also suppliers of their suppliers, and multiple suppliers 
serving the same buyer.
Taking a network perspective, integrating the care chain with the supply chain, 
and integrating purchasing of care with purchasing for care, all result in increasing 
complexity of the object of study. I believe we need to break up the area of research into 
smaller pieces, but that we should keep in mind the overall perspective of the healthcare 
system as a value network.
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8. Triple impact
With my research in the area of purchasing and supply management in healthcare, my 
aim is not to achieve double impact, as some colleagues claim is needed, but I would 
like to achieve triple impact.
The first type of impact is impact on the scholarly community through publications in 
reputable journals. These include journals in operations and supply management, but 
also journals in health services research. It struck me that there is little cross-fertilisation 
between purchasing and supply management and health services research. The first 
book I read on purchasing of care – just under 300 pages thick – had not one reference 
to the PSM literature (Figueras et al, 2005). I aim to use my diverse background in 
strategy, marketing and purchasing management to help solve complex problems in 
health services research. And to do that of course in collaboration with colleagues 
from both the institute of Health Policy & Management and the Rotterdam School of 
Management.
The second type of impact is impact on purchasing professionals and policymakers 
in the healthcare sector through direct interaction with such practitioners. The field 
experiments executed by Peter Dohmen are one example of having direct impact 
on practitioners through research. Fabian Nullmeier will also directly engage supply 
management professionals in his research. Some claim that there is a trade-off between 
the rigour and the relevance of academic research, suggesting that rigorous research 
leads to impact on the scholarly community, and relevant research to impact on 
practice. I see rigour as a necessary, but not sufficient condition for relevance. Before 
theories can be safely used by practitioners, they need to have shown robustness, in 
other words, they need to have undergone repeated rigorous testing (Van Weele & Van 
Raaij, 2014). Providing advice through committees is another road to achieve impact on 
policies and practices.
The third type of impact is impact on students through teaching. The course 
on purchasing and supply management in healthcare started in 2011 and is still 
running strong after two name changes. The course is now open to both healthcare 
management and supply chain management students. As an innovative feature, real 
purchasers for care participate in our negotiation skills workshop. I also teach a course 
on empirical research methods, and I aspire to also have an impact on student’s thinking 
about what good empirical research entails. As an impactful innovation, I changed this 
research methods course into a blended format, boosting student satisfaction with the 
course (Figure 12), and also my own satisfaction in teaching it.
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Figure 12: Student evaluations of the research methods course in traditional and blended formats
In this research methods course, I expose supply chain management students to design 
studies as a research methodology (Van Aken et al., 2012). I see design research as an 
important enabler to achieve triple impact. Design research is by definition executed 
in close interaction with practitioners. In both sections where this chair is established, 
the Supply Chain Management section at RSM and the Health Services Management & 
Organisation section at iBMG, design studies are accepted as a third type of empirical 
research strategy for Master thesis projects, next to theory building and theory testing 
strategies. I intend to remain an advocate of this particular research strategy.
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9. Conclusion
I started this inaugural address by defining purchasing and supply management and 
defining value. I then elaborated on purchasing for care and purchasing of care. In both 
contexts, it is not enough to look at dyadic buyer-supplier relationships. Purchasing for 
care takes place in a tetradic relationship setting and requires a focus on the purchaser, 
user, supplier and board. Purchasing of care takes place in a triadic setting and requires 
a focus on the financer, provider and patient. Purchasing for care and purchasing of 
care can be integrated in a value chain perspective, with all actors in the value chain 
ultimately aligned around creating value for the patient. This means creating the best 
possible health outcomes per euro.
While it is not my intention to propose a new definition of purchasing and supply 
management in general, the above discussion calls out for a definition of purchasing 
and supply management in healthcare that captures patient value as the compass for all 
purchasing activities. Hence, I would like to propose the following definition specific for 
the research area of my chair. Purchasing and supply management in healthcare is:
“The design, initiation, control and evaluation of activities within and between 
organisations aimed at realising patient value with supplier-partners at the most 
favourable conditions.”
This means that purchasing and supply managers should be aware of what health 
outcomes matter to patients. The efforts of the International Consortium on Health 
Outcome Measurement (ICHOM) are very valuable in this respect. Taking patient value 
as the compass for purchasing is a key characteristic of the highest level of purchasing 
maturity. 
Contract designs, including outcome-based contracting, and payment structures, 
including pay-for-performance, are receiving due attention in academic research, 
amongst others at the Rotterdam School of Management (Selviaridis & Wynstra, 2015; 
Nullmeier et al., 2016) and the institute for Health Policy and Management (Eijkenaar, 
2013). It is not clear yet, however, what 
purchasing maturity means for purchasing and supply management in healthcare. 
Moreover, little attention has been paid to understanding how specific approaches to 
supplier selection, contracting, and relationship management relate to trust between 
partners in the healthcare value network, to patient outcomes, and to health service 
performance. Through my research, I want to help purchasing and supply management 
professionals in the healthcare sector achieve higher maturity and better health 
outcomes for patients. I want to achieve this through direct engagement with healthcare 
organisations and through teaching future generations of healthcare professionals.
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